Hao Sun¹, Romanos Sklavenitis-Pistofidis, MD², Xia Liu, MD^1*, Nickolas Tsakmaklis^1*, Maria Luisa Guerrera, MD¹, Amanda Kofides, BA^1*, Andres Felipe Ramirez Gamero, MD^1*, Catherine A. Flynn, NP^1*, Christopher J Patterson, MPH, MBA^1*, Mu Hao, MD^3*, Lu-Gui Qiu, MD⁴, Shayna R Sarosiek¹, Jorge J. Castillo, MD¹, Zachary R Hunter, PhD¹, Shirong Liu, MD, PhD¹ and Steven P. Treon, MD, PhD, FRCP¹

¹Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA
²Broad Institute of MIT and Harvard, Cambridge, MA
³Chinese Academy of Medical Sciences and Peking Union Medical College, Institute of Hematology and Blood Diseases Hospital, Tianjin, China
⁴State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China

Vijai Joseph, PhD^1*, Alyssa I Clay-Gilmour, PhD^2,3, Hanla Park, Ph.D.^4*, Charles Breeze, Ph.D.^5*, Lara E. Sucheston-Campbell, PhD, MS⁶, Joshua Arias^7*, Rosalie Griffin Waller, PhD^8*, Murat Güler^9*, Alexandra Nieters^10*, Karin Ekstroem Smedby, MD¹¹, Ólafur Birgir Davídsson, Ph.D.^12*, Sophia S. Wang, PhD^13*, Qing Lan, Ph.D.^14*, Henrik Hjalgrim, MD, DMSc^15,16*, Susan L. Slager, PhD⁸, James McKay, Ph.D.^17*, James R. Cerhan, MD, PhD⁸, Sonja I. Berndt, PhD, PharmD^5* and Nathaniel Rothman, M.D, M.P.H.^5*

¹Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Epidemiology and Biostatistics, University of South Carolina, Columbia, SC
³Department of Epidemiology and Biostatistics, University of South Carolina, Simpsonville, SC
⁴International Agency for Research on Cancer, Lyon, France
⁵Division of Cancer Epidemiology and Genetics, National Cancer Institute / National Institute of Health, Bethesda, MD
⁶College of Pharmacy, The Ohio State University, Pleasanton, CA
⁷Division of Cancer Epidemiology and Genetics, National Cancer Insititute, National Institute of Health, Bethesda, MD
⁸Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
⁹German Cancer Research Center, Heidelberg, Germany
¹⁰Institute for Immunodeficiency, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany
¹¹Karolinks Institutet, Stockholm, Sweden
¹²Danish Cancer Institute, Copenhagen, Denmark
¹³City of Hope Comprehensive Cancer Center, Duarte, CA
¹⁴Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD
¹⁵The Danish Cancer Society, Copenhagen, Denmark
¹⁶Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
¹⁷Genomic Epidemiology branch, International Agency for Research on Cancer/World Health Organization (IARC/WHO), Lyon, FRA

Katherine Antel, MD, PhD^1,2, Mwanasha H. Merrill, MD³, Nina Xiong^1*, Lauren McGrath^1*, Meng-Xuan Wu^1*, Maxine van der Schyff^2*, Charlotte Slome^2*, Jonathan Day^2*, Dylan Cheddie^2*, Clara E. Droessler^1*, Liam McBride^1*, Michael Y. Tolstorukov, PhD^4*, Elizabeth F. Cohen, MRes^4*, Mikaela M. McDonough^1*, Zainab Mohamed, MBChB, MMed^2*, Estelle Verburgh, MBChB, M Med Int, FCPSA, PhD², Nazia Fakie^2*, Nomonde Mbatani^2*, Charlotte Schultz^2*, Graeme Meintjes^2* and Mark A. Murakami, MD⁵

¹Dana-Farber Cancer Institute, Boston, MA
²University of Cape Town, Cape Town, South Africa
³Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
⁴Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁵Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Evgeniia Alekseeva, PhD^1*, Vasiliy Minkov, MS^1*, Alexander Nesmelov, PhD^2*, Mikhail Shugay, PhD^1*, Nathan Fowler, MD¹, Alexander Bagaev, PhD^2* and Nikita Kotlov, PhD^2*

¹BostonGene, Corp., Waltham, MA
²BostonGene Corp., Waltham, MA

Neha Mehta-Shah, MD¹, Steven Horwitz, MD², Pier Luigi Zinzani, MD³, Stefan K. Barta, MD⁴, Makoto Yamagishi, PhD^5*, David M. Kurtz, MD, PhD^6*, Gensuke Takayama, PhD^7*, Yoshiyuki Hizukuri, PhD^7*, Weiguo Feng, PhD^7*, Ken C. N. Chang, PhD^7*, Takaya Moriyama, MD, PhD^7*, Keiko Nakajima, MD, MSc^7*, Ai Inoue, MD, PhD^7* and Emmanuel Bachy, MD, PhD⁸

¹School of Medicine, Washington University, St. Louis, MO
²Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
³IRCCS Azienda Ospedaliero-Universitaria di Bologna  Istituto di Ematologia “Seràgnoli” and Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy
⁴Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁵Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, JPN
⁶Foresight Diagnostics, Aurora, CO
⁷Daiichi Sankyo Inc., Basking Ridge, NJ
⁸Department of Hematology, Lyon-Sud Hospital Center, Pierre-Bénite, France

Pierre-Edouard Debureaux, MD^1,2, Stephanie Poulain, MD^3*, Marie Passet, Pharm.D. / Ph.D.^4*, Marie Temple^5*, Chloé Friedrich^5*, Nathalie Forgeard, MD^6*, Dikelele Elessa, MD^4*, William Plas^4*, Laureen Chat^4*, Gregory Lazarian, PharmD^7*, Lise Willems^8*, Bruno Royer, MD^6*, Alexis Talbot^4*, Tristan Vaugeois, MD^6*, Floriane Theves^4*, Alexandre Terre^9*, Anne Brignier, MD^4*, Marion Malphettes^4*, Daphne Krzisch, MD^10*, Laurent Frenzel, MD, PhD^11*, Frederic Davi^12*, Clothilde Bravetti^12*, Florence Nguyen-Khac, MD, PhD^12*, Jehan Dupuis, MD^13*, Wendy Cuccuini, MD, PhD^4*, Didier Bouscary, MD, PhD^14*, Olivier Hermine, MD, PhD¹¹, Damien Roos-Weil^15*, Olivier Kosmider, PharmD, PhD^16*, Emmanuelle Clappier, Pharm.D., Ph.D.^4,17*, Marion Espeli^2*, Karl Balabanian, PhD^2* and Bertrand Arnulf, MD¹⁸

¹Immuno-Hematology Unit, Saint Louis Hospital, APHP, Paris, France
²U1160, IRSL, Paris, France
³CHRU de Lille, Lille, FRA
⁴Saint Louis Hospital, Paris, France
⁵Hôpital Cochin, Paris, France
⁶Department of Immuno-hematology, Hôpital Saint Louis, APHP, Paris, France
⁷GHUPSSD Hôpital Avicenne AP-HP, PARIS, France
⁸Service d'hématologie clinique, Hôpital Cochin, Université de Paris, APHP, Paris, France
⁹Tenon Hospital, Paris, France
¹⁰Hopital Saint Louis, Assistance Publique - Hopitaux de Paris, Paris, France
¹¹Hematology, Necker Hospital, Greater Paris University Hospitals (AP-HP), Paris, France
¹²Hopital Pitie-Salpetriere, Paris, France
¹³APHP, Creteil, Creteil, FRA
¹⁴Hematology, Cochin Hospital, Greater Paris University Hospitals (AP-HP), Paris, France
¹⁵Hôpital Pitié-Salpétrière, Paris, FRA
¹⁶Laboratory of Hematology, Université Paris Cité and Assistance Publique-Hôpitaux de Paris. Centre, Hôpital Cochin, Paris, France
¹⁷INSERM U944/CNRS UMR7212, Institut de Recherche Saint- Louis, Université Paris Cité, Paris, France
¹⁸Immuno-hematology, Saint Louis Hospital, Paris Cedex 10, France

Samantha Beck¹, Sophia Maharry Roush^2*, Marriam Mponda, MBBS^3*, Edwards Kasonkanji, MPH^4*, Tamiwe Tomoka, MD^5*, Matthew S Painschab, MD^4,6, Jonathan Galeotti^7*, Kate D. Westmoreland, MD^8* and Yuri D. Fedoriw, MD^4,9

¹Pathobiology & Translational Science, University of North Carolina at Chapel Hill, Carrboro, NC
²Pathobiology & Translational Science, University of North Carolina at Chapel Hill, Chapel Hill, NC
³UNC Project Malawi, Lilongwe, MWI
⁴UNC Project-Malawi, Lilongwe, Malawi
⁵Kamuzu Central Hospital, Lilongwe, Lilongwe, MWI
⁶Division of Hematology, University of North Carolina, Chapel Hill, NC
⁷University of North Carolina, Chapel Hill, NC
⁸UNC Project Malawi, Chapel Hill, NC
⁹Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC

Dong Thanh Le^1,2*, Viet Hoang Nguyen^3*, Giang Hoang Thao Nguyen^1*, Akiyoshi Takami, MD, PhD⁴ and Luis Espinoza, MD, PhD^5*

¹Kanazawa University, Kanazawa, Japan
²Faculty of Medical Technology, Hanoi Medical University, Hanoi, Viet Nam
³Hanoi Medical University, Hanoi, Viet Nam
⁴Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan
⁵Faculty of Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan

Manik Uppal, MD^1*, Ashwath Gurumurthi, MBBS^2*, Paul A. Hamlin, MD³, Lorenzo Falchi, MD³, Steven Horwitz, MD³, Anita Kumar, MD⁴, Ariela Noy, MD³, Jennifer Kimberly Lue, MD³, Pallawi Torka, MD³, Maria E. Arcila, M.D.^5*, Ahmet Dogan, MD, PhD⁶, Brandon S. Imber, MD, MA⁷, Joachim Yahalom, MD⁷, Olivier Elemento, PhD, MS, BS⁸, Andrew D. Zelenetz, MD, PhD³, Gilles Salles, MD, PhD⁹ and Erel Joffe, MD^10*

¹The Mount Sinai Hospital, New York City, NY
²Memorial Sloan Kettering Cancer Center, New York City
³Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Short Hills, NJ
⁵Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Memorial Sloan Kettering Cancer Center, New York, NY
⁷Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Englander Institute for Precision Medicine/ Weill Cornell Medicine, Weill Cornell Medicine, New York, NY
⁹Lymphoma Service Chief, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁰Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

Wei Liu^1*, Changming Dong^2*, Yi Wang^2*, Ting Xie^3*, Shunjin Zhang^4*, Xiaoxia Wang^4*, Jinghua Wu^4*, Xiao Liu^5*, Dehui Zou^2* and Lu-Gui Qiu²

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China
²State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
³State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjing, China
⁴NeoImmune Co., LTD, Shenzhen, China
⁵Shenzhen International Graduate School, Tsinghua University, Shenzhen, China

Michelle J. Lee, MD, PhD¹, Kumudha Balakrishnan, MPhil, MSc, PhD^2*, Arman Petrosyants, MS^3*, Daniil Wiebe, PhD^3*, Chijioke Nze, MD, MPH², Neha Akkad, MD², Amy Ayers^2*, James D. Ayres^4*, Timothy J. McDonnell, MD, PhD^4*, Pavel Zemskiy, MS^3*, Kiril Kriukov, MD^3*, Alexander Nesmelov, PhD^3*, Ksenia Zornikova, PhD^3*, Krystle Nomie, PhD^3*, Alexander Sarachakov, MS^3*, Nikita Kotlov, PhD^3*, Ankur Singh, PhD^5*, Jean L. Koff, MD, MSc¹ and Christopher R. Flowers, MD, MS²

¹Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³BostonGene Corp., Waltham, MA
⁴Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA

Ying Yu^1*, Yuting Yan, MD^2*, Xiong Wenjie, MD^2*, Jun Wang^3*, Yao Yao, PhD^4*, Yuxi Li^1*, Tingyu Wang^5*, Rui Lyu, MD^1*, Hao Sun^6*, Qi Wang, MD^1*, Wei LIU^7*, Gang An^6*, Weiwei Sui, MD^1*, Yan Xu^8*, Wenyang Huang, MD^1*, Zhen Yu^6*, Dehui Zou^6*, Mu Hao, MD^6*, Zhi-jian Xiao^1*, Jianxiang Wang, MD⁸, Lu-Gui Qiu⁶ and Shuhua Yi, MD^1*

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
²State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
³State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, Germany
⁴State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China
⁵State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sci, Tian Jin, China
⁶State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁷State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology Blood Diseases Hospital, Chinese Academy of Medical Sciences Peking Union Medical College, Tianjin, China
⁸State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China

Satishkumar Singh, PhD¹, Alessandro La Ferlita, Ph.D^2*, Neeraj Jain, PhD³, Maxine Berger^4*, Sriya Sreekanth^2*, Rosario Distefano^4*, Mamta Gupta, PhD⁵, Natarajan Muthusamy, PhD, DVM⁶, Robert Baiocchi, MD, PhD⁷, Lapo Alinari, MD, Ph.D⁷, Narendranath Epperla, MD, MS⁸ and Lalit Sehgal, PhD^9,10

¹Division of Hematology, College of Medicine., The Ohio State University, Columbus, OH
²Division of Hematology, College of Medicine, The Ohio State University, Columbus, OH
³Central Drug Research Institute, Lucknow, Uttarpradesh, UTTAR PRADESH, IND
⁴Division of Hematology, College Of Medicine, The Ohio State University, Columbus, OH
⁵Department of Biochemistry and Molecular Medicine, George Washington University, Washington, DC
⁶The Ohio State University, Columbus, OH
⁷Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
⁸Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁹James Comprehensive Cancer Center, The Ohio State University, Columbus, OH
¹⁰Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH

Ramón Diez-Feijóo Varela, MD^1,2*, Marta Lafuente^1*, Nieves Garcia-Gisbert, PhD^1,3*, Concepción Fernández-Rodríguez^1,4*, Blanca Sánchez-González^1,5*, Joan Gibert, PhD^1*, Lierni Fernández-Ibarrondo, PhD^1*, Laura Camacho^1,4*, Raquel Longarón^1,4*, Luis Colomo^4*, Ana Ferrer, MD, PhD^4*, Christelle Ferrà, PhD^1*, Marta Salido, PhD^4*, Antonio Salar, MD^1* and Beatriz Bellosillo^1,4*

¹Hospital del Mar Research Institute, Barcelona, Spain
²Department of Hematology, Hospital del Mar, Barcelona, Spain
³Department of Hematology, Cambridge Stem Cell Institute, Cambridge, United Kingdom
⁴Department of Pathology, Hospital del Mar, Barcelona, Spain
⁵Hematology Department, Hospital del Mar, Barcelona, Spain

Philipp Nakov, MD^1*, Daniela Drandi^2*, Lisa Marie Kaiser^3*, Dajana Kaszynski^3*, Alexander Grunenberg, MD^4*, Jasmin Mark^3*, Elke Runge^3*, Meletios Dimopoulos, MD⁵, Efstathios Kastritis, MD^5*, Tina Bagratuni, PhD^5*, Christian Buske, MD^3,4, Christiane Pott, MD^1*, Simone Ferrero, MD² and Mouhamad Khouja, MSc^1*

¹Department of Internal Medicine II (Hematology/Oncology), University Hospital Schleswig-Holstein, Kiel, Germany
²Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy
³Institute of Experimental Cancer Research, University Hospital Ulm, Ulm, Germany
⁴Department of Hematology and Oncology, University Hospital Ulm, Ulm, Germany
⁵National and Kapodistrian University of Athens, Athens, Greece

Vincent Camus, MD, PhD^1,2*, Mathieu Viennot^1*, Victor Bobée, PharmD^3*, Pierre-Julien Viailly, PhD^1*, Elodie Bohers, PhD^4*, Vinciane Rainville^1*, Marie-Delphine Lanic, PhD^1*, Elena-Liana Veresezan, MD^5,6*, Fanny Drieux, MD, PhD^5,6*, Emilie Leveque, PhD^7*, Pascaline Etancelin, PharmD^8*, Dominique Penther, MD^9*, Hervé Tilly^1,2, Alexandra Zduniak, MD^2*, Philippe Ruminy, PhD^1* and Fabrice Jardin, MD, PhD^1,2*

¹INSERM U1245, Cancer and Brain Genomics, Centre Henri Becquerel, University of Rouen, Rouen, France
²Department of Hematology, Centre Henri Becquerel, Rouen, France
³University of Rouen, Charles Nicolle University Hospital, Rouen, FRA
⁴INSERM U1245, Cancer and Brain Genomics, Centre Henri Becquerel, University of Rouen, ROUEN, France
⁵Inserm U1245, Centre Henri Becquerel, UNIROUEN, University of Normandie, Rouen, France
⁶Department of Pathology, Centre Henri Becquerel, Rouen, France
⁷Clinical Research Unit, Centre Henri Becquerel, Rouen, FRA
⁸Department of Genetic Oncology and Inserm U1245, Centre Henri Becquerel, Rouen, FRA
⁹Department of Genetic Oncology and Inserm U1245, Centre Henri Becquerel, Rouen, France

Vincent Camus, MD, PhD^1,2,3*, Pierre Sesques, MD^4*, Alessio Bruscaggin, PhD^3*, Daphne Krzisch, MD^5*, Mathieu Viennot^1*, Luc-Matthieu Fornecker, MD, PhD^6*, Morgane Cheminant, MD, PhD^7*, Sébastien Bailly, MD^8*, Franck Morschhauser^9,10, Pierre Feugier, MD, PhD^11*, Sylvain Choquet, MD^12*, Eric Durot, MD^13*, Sylvain Carras, MD, PhD^14,15*, Caroline Delette, MD^16*, Gandhi Damaj, MD, PhD^17*, Agathe Waultier-Rascalou, MD^18*, Pierre Lebreton, MD^19,20*, Katell Le Du, MD^21*, Krimo Bouabdallah, MD^22*, Roch Houot, MD, PhD^23*, Stéphane Vigouroux, MD^24*, Kamel Laribi^25*, Laure Lebras, MD^26*, Lucie Oberic, MD^27*, Sandy Amorim, MD^28*, Simone Bocchetta, PhD^3*, Pierre-Julien Viailly, PhD^1*, Vinciane Rainville^1*, Philippe Ruminy, PhD^1*, Melody Caillot, PhD^29*, Lodovico Terzi Di Bergamo^30*, Georgia Alice Galimberti^3*, Maria Cristina Pirosa, MD³, Matin Salehi^3*, Gabriela Forestieri^3*, Fanny Drieux, MD, PhD^29*, Elena-Liana Veresezan, MD^29*, Alexandra Traverse-Glehen, MD, PhD^31*, Marie Donzel, MD^31*, Emilie Leveque, PhD^32*, Lucie Burel^33*, Elodie Bohers, PhD^34*, Marie-Delphine Lanic, PhD^1*, Pascaline Etancelin, PharmD^35*, Stéphanie Becker, MD, PhD^36*, Pierre Decazes, MD, PhD^37*, David Tonnelet, MD^37*, Simon Draye-Carbonnier, MD^36*, Hervé Tilly¹, Fabrice Jardin, MD, PhD^1* and Davide Rossi, MD, PhD³

¹INSERM U1245, Cancer and Brain Genomics, Centre Henri Becquerel, University of Rouen, Rouen, France
²Centre Henri Becquerel, Department of Hematology, Rouen, France
³Institute of Oncology Research, Laboratory of Experimental Hematology, Bellinzona, Switzerland
⁴CHU Lyon-Sud, Hospices Civils de Lyon, Lyon, France
⁵Hopital Saint Louis, Assistance Publique - Hopitaux de Paris, Paris, France
⁶Institut De Cancérologie Strasbourg Europe, Hematology Department, Strasbourg, France
⁷Hopital Necker - Enfants Malades, AP-HP, Department of Hematology, Paris, France
⁸Centre Hospitalier Universitaire de Clermont-Ferrand, CLERMONT FERRAND, France
⁹Centre Hospitalier Universitaire de Lille - Hopital Claude Huriez, Lille, France
¹⁰Hôpital Claude Huriez Univ. Lille, CHU Lille, Lille, France
¹¹CHU Brabois - Service d'Hématologie - Université Henri Poincaré, Nancy, France
¹²Hopital Pitié-Salpetriere, AP-HP, Paris, FRA
¹³Centre Hospitalier Universitaire de Reims, Reims Cedex, France
¹⁴University Grenoble Alpes, Institute for Advanced Biosciences, University Hospital, La Tronche, France
¹⁵CHU GRENOBLE - HÔPITAL ALBERT MICHALLON, Grenoble, France
¹⁶CHU Amiens Picardie - Oncopole Hopital Sud, Amiens, FRA
¹⁷CHU Caen, Caen, Normandy, FRA
¹⁸Nimes University Hospital, Nimes, France
¹⁹Groupe Hospitalier du Havre, Le Havre, France
²⁰Department of Hematology, Centre Henri Becquerel, ROUEN, France
²¹The Confluent, Private Hospital, Nantes, France
²²Bordeaux university hospital, Haut-Leveque, Department of hematology, Bordeaux, France
²³CHU Rennes, Univ Rennes, Inserm & EFS, Rennes, France
²⁴Centre Hospitalier Départemental - Service d'Onco-Hématologie, La Roche Sur Yon Cedex 9, FRA
²⁵Hématologie Clinique, CH Le Mans, Le Mans, France
²⁶Centre Leon Berard, Lyon, FRA
²⁷IUCT - Oncopole, Hematology Department, Toulouse, France
²⁸Hematology department, Hôpital Saint Vincent-De-Paul, LILLE CEDEX, France
²⁹Inserm U1245, Centre Henri Becquerel, UNIROUEN, University of Normandie, Rouen, France
³⁰Institute of Oncology Research, Bellinzona, CHE
³¹Hospices Civils de Lyon/Université Lyon 1, CHU Lyon-Sud, Pathology Department, Lyon, France
³²Clinical Research Unit, Centre Henri Becquerel, Rouen, FRA
³³Clinical Research Unit, Centre Henri Becquerel, Rouen, France
³⁴INSERM U1245, Cancer and Brain Genomics, Centre Henri Becquerel, University of Rouen, ROUEN, France
³⁵Department of Genetic Oncology and Inserm U1245, Centre Henri Becquerel, Rouen, FRA
³⁶Department of Nuclear Medicine, Centre Henri Becquerel, Rouen, France
³⁷Department of Nuclear Medicine, Centre Henri Becquerel, Rouen, FRA

Julia Mattlener^1,2*, Justin Ferdinandus, MD^3,4*, Jessica Schneider^1*, Julia K. Schleifenbaum, MD^1*, Max Freihammer^1*, Olivia Käsgen^1,2*, Hodgkin Lymphoma MRD Consortium^5*, Helen Kaul, Dipl.-Math.^2,6*, Gundolf Schneider, MSc^6*, Peter Borchmann, MD^3,7,8, Jan-Michel Heger, MD^9* and Sven Borchmann, MD/PhD^1,10*

¹Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany, Cologne, Germany
²German Hodgkin Study Group (GHSG), Cologne, Germany
³German Hodgkin Study Group, Cologne, Germany
⁴University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, and Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Cologne, Germany
⁵The Hodgkin Lymphoma MRD Consortium, Amsterdam, Netherlands
⁶Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany
⁷University Hospital Cologne, Cologne, Germany
⁸University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, and Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), and German Hodgkin Study Group (GHSG), Cologne, Germany
⁹Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany
¹⁰Liqomics GmbH, Cologne, Germany, Cologne, Germany

Cristina Zucchinetti, MD^1*, Chiara Signori^1*, Martina di Trani^2*, Maria Cristina Pirosa, MD^3,4,5, Alessio Bruscaggin, PhD^5*, Koorosh Korfi, PhD⁶, Alessia Bottos, PhD^7*, Eleonora Calabretta, MD^1,8*, Francesco Corrado, MD^9*, Davide Rossi, MD, PhD^5,10 and Carmelo Carlo-Stella, MD^2,11

¹Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy
²Department of Biomedical Sciences, Humanitas University, Milan, Italy
³Clinic of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland
⁴Faculty of Biomedical Science, Universita’ della Svizzera italiana, Lugano, Switzerland
⁵Institute of Oncology Research, Laboratory of Experimental Hematology, Bellinzona, Switzerland
⁶Roche Innovation Center Zurich, Roche, Schlieren, -- Select, Switzerland
⁷F. Hoffmann-La Roche Ltd, Basel, Switzerland
⁸Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁹Department of Medical Oncology, Jerome Lipper Center for Multiple Myeloma Research, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
¹⁰Università della Svizzera italiana, Faculty of Biomedical Science, Lugano, Switzerland
¹¹Department of Oncology and Hematology, IRCCS Humanitas Research Hospital, Rozzano, Italy

Jordan S Goldstein, MD, MSc¹, Florian Scherer, MD², Brian J. Sworder, MD, PhD³, Maximilian Diehn, MD, PhD^4*, David Kurtz, MD, PhD⁵ and Ash A. Alizadeh, MD, PhD⁶

¹Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Palo Alto, CA
²Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany
³Division of Hematology and Oncology, University of California, Irvine, Irvine, CA
⁴Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA
⁵Department of Medicine (Oncology), Stanford University, Palo Alto, CA
⁶Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA

Hanla Park, Ph.D.^1*, Mary Lou McMaster^2*, Zachary R Hunter, PhD³, Alyssa I Clay-Gilmour, PhD⁴, Lara E. Sucheston-Campbell, PhD, MS⁵, Charles Breeze, Ph.D.^6*, Joshua Arias^7*, Ólafur Birgir Davídsson, Ph.D.^8*, Karl Smith-Byrne^9*, Murat Güler^10*, Brenda M. Birmann, BA, DSc, MSc¹¹, Jonathan Hofmann^12*, Elizabeth E. Brown, PhD, MPH¹³, Shirley D’Sa, MD^14*, Charles Dumontet^15,16,17*, Nathaniel Rothman, M.D, M.P.H.^6*, Henrik Hjalgrim, MD, DMSc^18,19*, James R. Cerhan, MD, PhD²⁰, Susan L. Slager, PhD^21,22,23, Vijai Joseph, PhD^24*, James McKay, Ph.D.^25*, Steven P. Treon, MD, PhD, FRCP²⁶ and Sonja I. Berndt, PhD, PharmD^6*

¹International Agency for Research on Cancer, Lyon, France
²Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Insititute, National Institute of Health, Bethesda, MD
³Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA
⁴Arnold School of Public Health, Department of Epidemiology & Biostatistics, University of South Carolina, Columbia, SC
⁵College of Pharmacy, The Ohio State University, Pleasanton, CA
⁶Division of Cancer Epidemiology and Genetics, National Cancer Institute / National Institute of Health, Bethesda, MD
⁷Division of Cancer Epidemiology and Genetics, National Cancer Insititute, National Institute of Health, Bethesda, MD
⁸Danish Cancer Institute, Copenhagen, Denmark
⁹Cancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom
¹⁰German Cancer Research Center, Heidelberg, Germany
¹¹Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
¹²National Cancer Institute, Bethesda, MD
¹³Department of Pathology, University of Alabama At Birmingham, Birmingham, AL
¹⁴Centre for Waldenström’s Macroglobulinemia and Associated Disorders, University College London Hospital Foundation Trust, London, United Kingdom
¹⁵Cancer Research Center of Lyon, Lyon, FRA
¹⁶Centre De Biologie, Pierre-Bénite Cedex, FRA
¹⁷Ch Lyon Sud, Lyon, FRA
¹⁸The Danish Cancer Society, Copenhagen, Denmark
¹⁹Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark
²⁰Division of Epidemiology / Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
²¹Division of Computational Biology, Mayo Clinic, Rochester, MN
²²Division of Hematology, Mayo Clinic, Rochester, MN
²³Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
²⁴Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²⁵Genomic Epidemiology branch, International Agency for Research on Cancer/World Health Organization (IARC/WHO), Lyon, FRA
²⁶Department of Medical Oncology, Bing Center for Waldenstrom's Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

John M Hatcher, PhD^1*, Shirong Liu, MD, PhD¹, Amanda Kofides, BA^1*, Alexa G Canning, BA^1*, Dominic Pizzarella^1*, Jinhua Wang, PhD^2*, Xia Liu, MD^1*, Nickolas Tsakmaklis^1*, Maria Luisa Guerrera, MD¹, Christopher J Patterson, MPH, MBA^1*, Zachary R Hunter, PhD¹, Shayna R Sarosiek¹, Jorge J. Castillo, MD¹, Sara J. Buhrlage, PhD^2* and Steven P. Treon, MD, PhD, FRCP¹

¹Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA
²Dana-Farber Cancer Institute, Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA

Yannick Le Bris, PharmD, PhD^1*, Barbara Burroni, MD^2*, Marguerite Fournier^3*, Morgane Cheminant, MD, PhD^4*, Sara Ek, PhD^5*, Eva Hoster, PhD, Prof.^6*, Marie-Helene Delfau-Larue, MD, PhD^7*, Clémentine Sarkozy^8*, Mary B. Callanan, PhD^9*, Benoit Tessoulin, MD, PhD^10*, David Chiron, PhD^11*, Martin Dreyling, MD¹², Mats Jerkeman, MD, PhD¹³, Steven Le Gouill, MD, PhD¹⁴ and Olivier Hermine, MD, PhD¹⁵

¹Hematobiology, Nantes University Hospital, Nantes, France
²Pathology, Cochin, Paris, FRA
³LYSARC, Pierre-Benite, France
⁴Hopital Necker - Enfants Malades, AP-HP, Department of Hematology, Paris, France
⁵Department of Immunotechnology, Lund University, Lund, Sweden
⁶University Hospital Munich, Munich, Germany
⁷Hôpital Henri Mondor, Creteil, FRA
⁸Hematology Department, Institut Curie, Saint Cloud, France
⁹CHU de Dijon, Université de Bourgogne, Dijon, France
¹⁰Department of hematology, Nantes university hospital, Nantes, France
¹¹CRCI²NA - Nantes - Angers Cancer and Immunology Research Center, Nantes, NY, France
¹²Department of Medicine III, Ludwig Maximilian University Hospital, Munich, Germany
¹³Lund University Hospital, Lund, Sweden
¹⁴Institut Curie, Saint-Cloud, France
¹⁵CEREMAST Necker Hospital, Paris, France

Zijun Y. Xu-Monette, PhD¹, Xiaoxiao Wang^2*, Govind Bhagat, MD³, Alexandar Tzankov^4*, Qingyan Au^5*, Carlo Visco, MD^6,7*, Harry Nunns^8*, Alessandro La Ferlita, Ph.D^9*, Lalit Sehgal, PhD¹⁰, April Chiu, MD^11*, Heounjeong Go^12*, Anamarija M. Perry, MD¹³, Huilan Rao^2*, Mina Xu, MD^14*, Qiongli Zhai^15*, Yafei Wang^15*, Shi Wang^16*, Wenbin Qian^17*, Maurilio Ponzoni, MD^18,19, Wen Shuai^1*, Bangchen Wang, MD^1*, Sergio Pina-Oviedo, MD^1*, Luis Carrillo, MD^1*, Kelly Au^20*, Santiago Montes-Moreno Sr., MD, PhD^21*, Karen Dybkaer, PhD^22*, Zenggang Pan, MD, PhD^23*, William Choi, MBBS, MRCP²⁴, Michael Møller^25*, Luigi Racioppi, MD, PhD^20*, Xiaohui Zhang, MD, PhD^26*, Jinming Song, MD, PhD^27*, Shanxiang Zhang, MD, PhD^28*, Youli Zu, MD, PhD^29*, Joo Y. Song, MD³⁰, Eric D. Hsi, MD³¹, Fenghuang Zhan, MD³², Benjamin M. Parsons, DO³³, Aliyah R. Sohani, MD^34*, Weina Chen, MD, PhD^35*, Fabio Iwamoto^36*, Jeremy S. Abramson, MD³⁷, Bing Xu^38*, Yong Li, PhD³⁹ and Ken H. Young, MD, PhD⁴⁰

¹Department of Pathology, Duke University Medical Center, Durham, NC
²Sun Yat-Sen University Cancer Center, Guangzhou, China
³Department of Pathology & Cell Biology, Columbia University, New York, NY
⁴Medical University Basel, Basel, Switzerland
⁵NeoGenomics Laboratories, Aliso Viejo, CA
⁶Department of Engineering for Innovation Medicine/Section of Hematology, University of Verona, Verona, Italy
⁷Hematology and Bone Marrow Transplant Unit, Department of Engineering for Innovative Medicine, University of Verona, Verona, Italy
⁸Neogenomics Laboratories, Aliso Viejo, CA
⁹Division of Hematology, College of Medicine, The Ohio State University, Columbus, OH
¹⁰James Comprehensive Cancer Center, The Ohio State University, Columbus, OH
¹¹Division of Hematopathology, Mayo Clinic, Rochester, MN
¹²Asan Medical Center Children's Hospital, Seoul, KOR
¹³Department of Pathology, University of Michigan, Ann Arbor, MI
¹⁴Yale University, New Haven, CT
¹⁵Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
¹⁶National University Hospital, Singapore, Singapore, Singapore
¹⁷The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
¹⁸Pathology Unit, San Raffaele H. Scientific Institute, Milano, Italy
¹⁹Pathology Unit, IRCCS San Raffaele Scientific Institute and Università Vita-Salute San Raffaele, Milan, Italy
²⁰Duke University, Durham, NC
²¹IDIVAL/Valdecilla, on behalf of GELTAMO., Santander, Spain
²²Department of Haematology, Aalborg University Hospital, Aalborg, Denmark
²³Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO
²⁴Tuen Mun Hospital, Happy Valley, NA, HKG
²⁵Odense University Hospital, Odense, DNK
²⁶Department of Pathology, H. Lee Moffitt Cancer Center, Tampa, FL
²⁷Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
²⁸Department of Pathology & Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN
²⁹Houston Methodist Hospital, Houston, TX
³⁰Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
³¹Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
³²Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR
³³Gundersen Lutheran Health System, La Crosse, WI
³⁴Department of Pathology, Maasachusetts General Hospital, Boston, MA
³⁵Department of Pathology, UT Southwestern Medical Center, Dallas, TX
³⁶Columbia University Irving Medical Center, New York
³⁷Massachusetts General Hospital Cancer Center, Boston, MA
³⁸The First Affiliated Hospital of Xiamen University and Institute of Hematology, Xiamen University, Xiamen, China
³⁹Department of Medicine, Baylor College of Medcine, Houston, TX
⁴⁰Duke Cancer Institute, Duke University Medical Center, Durham, NC

Riccardo Bomben, PhD^1*, Daniela Drandi^2*, Irene Della Starza, PhD^3*, Clara Bono^4*, Andrea Evangelista^5*, Omar Perbellini^6*, Tamara Bittolo, PhD^1*, Elisa Genuardi^7*, Massimo Degan, PhD^1*, Simone Ragaini^8*, Maria Chiara Tisi^9*, Anna Merli^10*, Francesca Quaglia^11*, Alessandro Re, MD^12*, Claudia Castellino^13*, Vittorio Ruggero Zilioli^14*, Francesco Piazza, MD^15*, Paolo Corradini, MD¹⁶, Stefan Hohaus^17,18,19*, Gerardo Musuraca, M.D., Ph.D.^20*, Francesca Gaia Rossi^21*, Benedetta Puccini, MD^22*, Federica Cavallo^23*, Filippo Ballerini^24*, Luca Arcaini, MD^25*, Valter Gattei, MD¹, Ilaria Del Giudice^26*, Sara Galimberti, MD^4*, Carlo Visco, MD^27* and Simone Ferrero, MD²⁸

¹Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy
²Hematology Division I, Department of Molecular Biotechnologies and Health Sciences, University of Turin/University Hospital A.O.U. “Città della Salute e della Scienza”, Torino, Italy, Italy
³AIL Roma ODV, Rome, Italy
⁴Department of Clinical and Experimental Medicine, Hematology, University of Pisa, Pisa, Italy
⁵Unit of Cancer Epidemiology, A.O.U Città della Salute e della Scienza di Torino, Torino, Italy
⁶Ospedale S. Bortolo – Ematologia, Vicenza - ULSS 8 Berica, Vicenza, Italy
⁷Department of Molecular Biotechnology and Health Sciences, Hematology Division, University of Torino, Torino, Italy
⁸Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy
⁹Hematology Unit, San Bortolo Hospital, A.U.L.S.S. 8 "Berica", Vicenza, Italy
¹⁰Ospedale degli Infermi di Rimini - U.O. di Ematologia, Rimini, ITA
¹¹Hematology Unit, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy, Verona, ITA
¹²Lymphoma Unit, Division of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
¹³A.O. S. Croce e Carle - S.C. di Ematologia e Trapianto di Midollo Osseo, Cuneo, Italy
¹⁴Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy, Milano, IT-MI, Italy
¹⁵UOC Di Ematologia Azienda Ospedale Università Padova, University of Padua, Padua, Italy
¹⁶Hematology Division, University of Milan. Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
¹⁷Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Roma, Italy
¹⁸Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy
¹⁹Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy
²⁰IRCCS Istituto Romagnolo per lo studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy
²¹Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, ITA
²²A.O.U. Careggi, Firenze, Italy
²³Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, A.O.U., Città della Salute e della Scienza di Torino, Torino, Italy
²⁴IRCCS Ospedale Policlinico San Martino, Genoa, Italy
²⁵Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
²⁶Hematology, Department of Translational and Precision Medicine, Sapienza University, Roma, Italy
²⁷Hematology and Bone Marrow Transplant Unit, Department of Engineering for Innovative Medicine, University of Verona, Verona, Italy
²⁸Department of Molecular Biotechnology and Health Sciences, Hematology Division, University of Torino, Torino, TO, Italy

Jisu Shin, MPH^1,2*, Jeff C Xing, BS^3*, Thomas P. Loughran Jr., MD⁴, David J Feith, BS, PhD^4* and Aakrosh Ratan, PhD⁵

¹School of Medicine, University of Virginia, Charlottesville, VA
²Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA
³University of Virginia, Charlottesville, VA
⁴UVA Comprehensive Cancer Center, Charlottesville, VA
⁵Department of Genome Sciences, University of Virginia, Charlottesville, VA

Dai Chihara, MD, PhD¹, Kumudha Balakrishnan, MPhil, MSc, PhD^1*, Gita Masand, PhD^1*, Robert Andrew Harkins, MD, MS², Neha Akkad, MD³, Anna Novokreshchenova, MS^4*, Alexander Bagaev, PhD^5*, Nikita Kotlov, PhD^5*, Ekaterina Postovalova, PhD^4*, Eduardo Shugaev-Mendosa, MD^4*, Yuliya Gracheva, MS^4*, Kelley Lauziere^4*, Leznath Kaneunyenye^4*, Brianna McKenna^4*, Amber Berlinski^4*, McKenna Walsh^4*, Linnea Larson^4*, Mariam Kotsinyan^4*, Anna Samokhina^4*, Sheila T Yong^4*, Krystle Nomie, PhD^5*, Nathan H. Fowler, MD^6*, Christopher R. Flowers, MD, MS¹ and Jason R. Westin, MD¹

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
³Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TT
⁴BostonGene, Corp., Waltham, MA
⁵BostonGene Corp., Waltham, MA
⁶BostonGene, Waltham, MA

Xiaoyang Sun^1,2*, Stephan de Bra^1,2*, Tatjana Schmitz^1*, Stefan Tholen, PhD^3*, Geoffroy Andrieux, PhD^4,5*, Uta Sabine Sabine Martens^6,7*, Melanie Boerries, MD, PhD^5,8*, Oliver Schilling, PhD^9,10*, Justus Duyster, MD^1,4,10* and Cornelius Miething, MD^1,4,10*

¹Department of Medicine I, Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
²Faculty of Medicine, Albert-Ludwigs-University Freiburg, Freiburg, Germany
³Institute of Clinical Pathology, University Medical Center Freiburg, Freiburg, DEU
⁴German Cancer Research Center (DKFZ), Heidelberg, Germany
⁵Institute of Medical Bioinformatics, University Medical Center Freiburg, Freiburg, Germany
⁶Department of Medicine I, Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg Im Breisgau, Germany
⁷Faculty of Chemistry and Pharmacy, Albert-Ludwigs-University Freiburg, Freiburg, Germany
⁸German Cancer Consortium (DKTK), Partner site Freiburg; and German Cancer Research Center (DKFZ), Freiburg, Germany
⁹Institute of Clinical Pathology, University Medical Center Freiburg, Freiburg, Germany
¹⁰German Cancer Consortium (DKTK), Partner site Freiburg; and German Cancer Research Center (DKFZ), Heidelberg, Germany

Bee S Tan^1*, Charles Yin, MD, PhD², Pankajkumar Tailor^1*, Bindu Thapa^1*, Carina Debes-Marun^1*, Deanna Hockley, PhD^1*, Irwindeep Sandhu, MD³ and Michael P. Chu, MD^4,5

¹University of Alberta, Edmonton, Canada
²University of Alberta, Edmonton, AB, Canada
³Cross Cancer Institute, Edmonton, AB, Canada
⁴Department of Medical Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
⁵Department of Oncology, University of Alberta, Edmonton, AB, Canada

Maher Albitar, MD¹, Hong Zhang, MD^1*, Sally Agersborg, MD, PhD^1*, Ahmad Charifa, MD^1*, Andrew L Pecora, MD², Lori A. Leslie, MD³, Tatyana Feldman, MD⁴, Andrew Ip, MD, MSc⁵ and Andre Goy, MD, MS⁵

¹Genomic Testing Cooperative, Lake Forest, CA
²Hackensack University Medical Center, Hackensack, NJ
³Lymphoma Division, John Theurer Cancer Center, Hackensack Meridian School of Medicine, Hackensack, NJ
⁴Hackensack Meridian Health Hackensack University Medical Center, NY, NY
⁵Lymphoma Division, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ